Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite

Bioorganic & Medicinal Chemistry Letters
2015.0

Abstract

Recent studies have highlighted a key role in regulating gene transcription, in both eukaryotes and prokaryotes, by enzymes that control the acetylation and deacetylation of histones. In particular, inhibitors of histone deacetylases (HDAC-Is) have been shown effective in controlling the development of many parasites, such as the plasmodium of malaria. Here we report the results of a study aimed at evaluating antiparasitic effect of two classes of HDAC-Is bearing different zinc binding group (hydroxamic acid vs thiol). The study showed that only the hydroxamic acid based HDAC inhibitors were active, with Plasmodium falciparum being the most sensitive parasite, having from low double-digit to single-digit nanomolar range in vitro activities. Among three derivatives evaluated also in vivo, ST8086AA1 (8) effectively inhibited 88% of the development of Plasmodium falciparum.

Knowledge Graph

Similar Paper

Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite
Bioorganic & Medicinal Chemistry Letters 2015.0
Potent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues
Antimicrobial Agents and Chemotherapy 2008.0
Ex VivoActivity of Histone Deacetylase Inhibitors against Multidrug-Resistant Clinical Isolates ofPlasmodium falciparumandP. vivax
Antimicrobial Agents and Chemotherapy 2011.0
Novel Inhibitor of Plasmodium Histone Deacetylase That Cures P. berghei- Infected Mice
Antimicrobial Agents and Chemotherapy 2009.0
Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages
European Journal of Medicinal Chemistry 2014.0
Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group
Bioorganic & Medicinal Chemistry 2010.0
Antimalarial Activity of Phenylthiazolyl-Bearing Hydroxamate-Based Histone Deacetylase Inhibitors
Antimicrobial Agents and Chemotherapy 2008.0
Identification and Characterization of Small Molecule Inhibitors of a Class I Histone Deacetylase from Plasmodium falciparum
Journal of Medicinal Chemistry 2009.0
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of Schistosomiasis
Journal of Medicinal Chemistry 2016.0
Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): A novel target for the development of antimalarial therapy
Bioorganic & Medicinal Chemistry 2008.0